Biblio

Author Title [ Type

] Year

Filters: Author is Gao, Li [Clear All Filters]

Journal Article

Gao L, Xiang X, Zhang C, Gao L, Yang T, Wang S, Li B, Lou S, Lou S, Liu Y, et al. Upfront autologous hematopoietic stem cell transplantation in patients with high-risk stage III to IV Hodgkin lymphoma: a multicenter retrospective cohort study. Hematology. 2019;24(1):225-231.

Dai M, Hua C, Wang M, Gao L, Jiang L, Liu Y. Targeting regulation of VEGF by BPTF in non-small cell lung cancer and its potential clinical significance. Eur J Med Res. 2022;27(1):299.

Xuan L, Wang Y, Chen J, Jiang E, Gao L, Wu B, Deng L, Liang X, Huang F, Fan Z, et al. Sorafenib therapy is associated with improved outcomes for FLT3-ITD AML relapsing after allo-HSCT. Biol Blood Marrow Transplant. 2019.

Zhang Y, Jiang S, He F, Tian Y, Hu H, Gao L, Zhang L, Chen A, Hu Y, Fan L, et al. Single-cell transcriptomics reveals multiple chemoresistant properties in leukemic stem and progenitor cells in pediatric AML. Genome Biol. 2023;24(1):199.

Zhang C, Ma Y-Y, Liu J, Liu Y, Gao L, Gao L, Kong P-Y, Xiong Q-H, Mei W-L, Liu J, et al. Preventive infusion of donor-derived CAR-T cells after haploidentical transplantation: Two cases report. Medicine (Baltimore). 2019;98(29):e16498.

Ma Y-Y, Wei Z-L, Xu Y-J, Shi J-M, Yi H, Lai Y-R, Jiang E-L, Bin Wang S-, Wu T, Gao L, et al. Poor pretransplantation minimal residual disease clearance as an independent prognostic risk factor for survival in myelodysplastic syndrome with excess blasts: A multicenter, retrospective cohort study. Cancer. 2023.

Wang L, Kong P, Zhang C, Gao L, Zhu L, Liu J, Gao S, Chen T, Liu H, Yao H, et al. Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-Genzyme. Ann Hematol. 2023.

Li B, Meng L, Tian Y, Lu Q, Gao L, Xiao P, Lu J, Li J, Wan L, Li Z, et al. Outcomes and risk factors of hemorrhagic cystitis in pediatric allogeneic hematopoietic stem cell transplantation recipients using different graft source and condition with severe aplastic anemia. Hematology. 2022;27(1):714-722.

Zhou S, Rao J, Ma X, Zeng Y, Xiang X, Li J, Liu H, Lin S, Dong S, Li F, et al. Optimized BEAC conditioning regimen improves clinical outcomes of autologous hematopoietic stem cell transplantation in non-Hodgkin lymphomas. Int J Hematol. 2024.

Huang RH, Chen T, Wang S, Wang J, Su Y, Liu J, Zhang Y, Ma X, Wen Q, Kong P, et al. Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell Transplant: An Open-Label Randomized Clinical Trial. JAMA Oncol. 2023.

Li C, Li B, Dong Z, Gao L, He X, Liao L, Hu C, Wang Q, Jin Y. Lipopolysaccharide differentially affects the osteogenic differentiation of periodontal ligament stem cells and bone marrow mesenchymal stem cells through Toll-like receptor 4 mediated nuclear factor kappaB pathway. Stem Cell Res Ther. 2014;5(3):67.

Gao L, Zhang Y, Wang S, Kong P, Su Y, Hu J, Jiang M, Bai H, Lang T, Wang J, et al. Effect of rhG-CSF Combined With Decitabine Prophylaxis on Relapse of Patients With High-Risk MRD-Negative AML After HSCT: An Open-Label, Multicenter, Randomized Controlled Trial. J Clin Oncol. 2020:JCO1903277.

Tan X, Wang X-Q, Zhang C, Zhao X-L, Yao H, Chen G, Ma Y-Y, Wen Q, Gao L, Gao L, et al. Donor-derived CD19 CAR-T Cells versus Chemotherapy Plus Donor Lymphocyte Infusion for Treatment of Recurrent CD19-positive B-ALL After Allogeneic Hematopoietic Stem Cell Transplantation. Curr Med Sci. 2023.

Yao D, Li B, Chu X, Pan J, Meng L, Hu Y, Gao L, Li J, Tian Y, Hu S. Association between CD34 and CD3 T-cells in allogeneic grafts and acute graft-versus-host disease in children undergoing allogeneic hematopoietic stem cell transplantation: A single-center study. Transpl Immunol. 2022:101779.